ARTICLE | Clinical News
Anti-vWF Nanobody: Extension study data
January 4, 2010 8:00 AM UTC
Data from 22 patients with stable angina undergoing percutaneous coronary intervention (PCI) in the open-label extension of a Phase Ib trial showed that IV ALX-0081 significantly inhibited vWF-mediate...